Phase II Clinical Trial of OPS-2071 in the Treatment of Irritable Bowel Syndrome of Diarrhea Type

Clinical trial NCT05923892 · COMPLETED

Trial details

NCT number: NCT05923892
Sponsor: Otsuka Beijing Research Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Irritable Bowel Syndrome of Diarrhea Type (IBS-D)

Start date: 2023-08-02
Primary completion: 2024-08-01
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.